1. Home
  2. RNTX vs FARM Comparison

RNTX vs FARM Comparison

Compare RNTX & FARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNTX
  • FARM
  • Stock Information
  • Founded
  • RNTX 2001
  • FARM 1912
  • Country
  • RNTX United States
  • FARM United States
  • Employees
  • RNTX N/A
  • FARM N/A
  • Industry
  • RNTX Biotechnology: Pharmaceutical Preparations
  • FARM Packaged Foods
  • Sector
  • RNTX Health Care
  • FARM Consumer Staples
  • Exchange
  • RNTX Nasdaq
  • FARM Nasdaq
  • Market Cap
  • RNTX 34.6M
  • FARM 37.4M
  • IPO Year
  • RNTX N/A
  • FARM N/A
  • Fundamental
  • Price
  • RNTX $1.43
  • FARM $1.76
  • Analyst Decision
  • RNTX Buy
  • FARM Hold
  • Analyst Count
  • RNTX 2
  • FARM 1
  • Target Price
  • RNTX $10.00
  • FARM $2.50
  • AVG Volume (30 Days)
  • RNTX 114.1K
  • FARM 67.5K
  • Earning Date
  • RNTX 11-13-2025
  • FARM 11-06-2025
  • Dividend Yield
  • RNTX N/A
  • FARM N/A
  • EPS Growth
  • RNTX N/A
  • FARM N/A
  • EPS
  • RNTX N/A
  • FARM N/A
  • Revenue
  • RNTX N/A
  • FARM $342,281,000.00
  • Revenue This Year
  • RNTX N/A
  • FARM $5.27
  • Revenue Next Year
  • RNTX N/A
  • FARM $3.78
  • P/E Ratio
  • RNTX N/A
  • FARM N/A
  • Revenue Growth
  • RNTX N/A
  • FARM 0.35
  • 52 Week Low
  • RNTX $1.04
  • FARM $1.34
  • 52 Week High
  • RNTX $4.40
  • FARM $3.29
  • Technical
  • Relative Strength Index (RSI)
  • RNTX 60.90
  • FARM 48.49
  • Support Level
  • RNTX $1.22
  • FARM $1.68
  • Resistance Level
  • RNTX $1.30
  • FARM $1.88
  • Average True Range (ATR)
  • RNTX 0.11
  • FARM 0.08
  • MACD
  • RNTX 0.00
  • FARM -0.00
  • Stochastic Oscillator
  • RNTX 66.15
  • FARM 36.53

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

About FARM Farmer Brothers Company

Farmer Bros Co is engaged in manufacturing, wholesaling, and distributing coffee, tea, and culinary products to food-service establishments and retailers in the United States. The company's customers include restaurants, hotels, offices, casinos, convenience stores, healthcare facilities, and other food-service providers. The company's product categories include roast and ground coffee, frozen liquid coffee, flavored and unflavored iced and hot teas, culinary products, spices, and other beverages, such as cappuccino, cocoa, granitas, and ready-to-drink iced coffee.

Share on Social Networks: